Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc EDTXF


Primary Symbol: T.EDT

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Dialco Medical Inc. Engages CROMSOURCE as Contract Research Organization Partner for DIMI IDE Trial

GlobeNewswire June 7, 2021

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire June 4, 2021

Spectral Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 14, 2021

Spectral Medical to Present at the Q2 Virtual Investor Summit on May 17th

Newsfile May 11, 2021

Spectral Medical's Wholly-Owned Subsidiary Dialco Medical Announces DIMI Usability Trial Posted on the ClinicalTrials.gov Website

GlobeNewswire May 5, 2021

Spectral Medical’s (TSX:EDT) Dialco secures 20-year licensing agreement for hemodialysis device

Trevor Abes  April 8, 2021

Spectral Medical's Dialco Medical Announces 20 Year Exclusive License Agreement for DIMI Hemodialysis System in the United States and Canada

GlobeNewswire April 8, 2021

Spectral Medical (TSX:EDT) subsidiary Dialco Medical announces receipt of Health Canada license for DIMI

Julia Kennedy  March 31, 2021

Spectral Medical's Wholly-Owned Subsidiary Dialco Medical Announces Receipt of Health Canada License for DIMI

GlobeNewswire March 31, 2021

Spectral Medical (TSX:EDT) releases financial results and shares positive results from the Tigris program

Julia Kennedy  March 26, 2021

Spectral Announces Fourth Quarter and Fiscal 2020 Results and Corporate Update

GlobeNewswire March 26, 2021

Spectral Medical (TSX:EDT) appoints Chris Seto as CEO

John Ballem  March 8, 2021

Spectral Medical Announces the Appointment of Chris Seto to CEO

GlobeNewswire March 8, 2021

Spectral Medical (TSX:EDT) engages Crescendo Communications to provide Investor Relations Services

John Ballem  March 4, 2021

Spectral Medical Engages Crescendo Communications to Provide Investor Relations Services in the United States

GlobeNewswire March 4, 2021

Spectral Medical to participate at the upcoming H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 2, 2021

Spectral Medical (TSX:EDT) subsidiary Dialco Medical granted FDA IDE authorization for a DIMI trial for home Hemodialysis use

John Ballem  February 23, 2021

Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical has been Granted FDA IDE Authorization to Conduct a Trial of DIMI for Home Hemodialysis Use

GlobeNewswire February 23, 2021

Spectral Medical (TSX:EDT) appoints Dr. John Kellum as Chief Medical Officer

Isabella Zavarise February 1, 2021

Spectral Medical Appoints Dr. John Kellum as Chief Medical Officer

GlobeNewswire February 1, 2021